CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377)

被引：0

作者：

Jordan, Stanley ^{[1
]}

Ammerman, Noriko ^{[1
]}

Toyoda, Mieko ^{[2
]}

Ge, Shili ^{[2
]}

Huang, Edmund ^{[1
]}

Peng, Alice ^{[1
]}

Sethi, Supreet ^{[1
]}

Najjar, Reiad ^{[1
]}

Ortiz, Edwin ^{[2
]}

Chu, Maggie ^{[2
]}

De Guzman, Abner ^{[2
]}

Kim, Irene ^{[1
]}

Lim, Kathlyn ^{[1
]}

Choi, Jua ^{[1
]}

Vo, Ashley A. ^{[1
]}

机构：

[1] Cedars Sinai Med Ctr, Kidney Transplant, Los Angeles, CA 90048 USA

[2] Cedars Sinai Med Ctr, Transplant Immunol Lab, Los Angeles, CA 90048 USA

来源：

TRANSPLANTATION | 2020年 / 104卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

380.2

引用

页码：S67 / S68

页数：2

共 50 条

[31] Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)
Vo, A. A.
Ammerman, N.
Huang, E.
Toyoda, M.
Ge, S.
Peng, A.
Najjar, R.
Sethi, S.
Williamson, S.
Myers, C.
Lim, K.
Gillespie, M.
Jordan, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 372 - 372
[32] Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection
Shin, Bong-Ha
Everly, Matthew J.
Zhang, Hao
Choi, J.
Vo, Ashley
Zhang, Xiaohai
Huang, Edmund
Jordan, Stanley C.
Toyoda, Mieko
TRANSPLANTATION, 2020, 104 (04) : 856 - 863
[33] The Analysis of Graft Outcomes Following Treatment in Chronic Antibody-Mediated Rejection in Kidney Transplantation
Park, J. B.
Kim, Y. H.
Chung, Y. S.
Song, K. B.
Jung, J. H.
Kim, S. -C.
Han, D. J.
TRANSPLANTATION, 2012, 94 (10) : 1052 - 1052
[34] Recurrent AA Amyloidosis Combined With Chronic Active Antibody-mediated Rejection After Kidney Transplantation
Yeo, Min-Kyung
Ham, Young Rok
Choi, Song-Yi
Lee, Yong-Moon
Park, Moon Hyang
Suh, Kwang-Sun
IRANIAN JOURNAL OF KIDNEY DISEASES, 2017, 11 (04) : 322 - 325
[35] PSMP Is Discriminative for Chronic Active Antibody-Mediated Rejection and Associate With Intimal Arteritis in Kidney Transplantation
Zhan, Panpan
Li, Haizheng
Han, Mingzhe
Wang, Zhen
Zhao, Jie
Tu, Jinpeng
Shi, Xiaofeng
Fu, Yingxin
FRONTIERS IN IMMUNOLOGY, 2021, 12
[36] Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation
Ryo Tanaka
Koichi Tsutahara
Shunsuke Inoguchi
Hiromu Horitani
Toshihisa Asakura
Norihiko Kawamura
Yoichi Kakuta
Masahiro Nakagawa
Tetsuya Takao
CEN Case Reports, 2022, 11 : 79 - 83
[37] Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation
Tanaka, Ryo
Tsutahara, Koichi
Inoguchi, Shunsuke
Horitani, Hiromu
Asakura, Toshihisa
Kawamura, Norihiko
Kakuta, Yoichi
Nakagawa, Masahiro
Takao, Tetsuya
CEN CASE REPORTS, 2022, 11 (01) : 79 - 83
[38] CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection
Doberer, Konstantin
Klaeger, Johannes
Gualdoni, Guido A.
Mayer, Katharina A.
Eskandary, Farsad
Farkash, Evan A.
Agis, Hermine
Reiter, Thomas
Reindl-Schwaighofer, Roman
Wahrmann, Markus
Cohen, Gerald
Haslacher, Helmuth
Bond, Gregor
Simonitsch-Klupp, Ingrid
Halloran, Philip F.
Boehmig, Georg A.
TRANSPLANTATION, 2021, 105 (02) : 451 - 457
[39] Anti-Interleukin 6 Therapeutics for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
Sharma, Rajeev
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 709 - 716
[40] Monitoring Inflammatory Cytokines in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts) Desensitized with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Followed by Transplantation (Tx)
Ge, S.
Petrosyan, A.
Chu, M.
Ammerman, N.
Vo, A.
Zhang, X.
Jordan, S. C.
Toyoda, M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 901 - 901

← 1 2 3 4 5 →